Detection of papillary thyroid carcinoma with serum protein profile analysis

William H. Moretz, Christine Gourin, David J. Terris, Zhong Sheng Xia, Zhongmin Liu, Paul M. Weinberger, Edward Chin, Bao Ling Adam

Research output: Contribution to journalArticle

Abstract

Objective: To determine the sensitivity and specificity of surface-enhanced laser desorption/ionization time-offlight mass spectrometry (SELDI-TOF-MS) for papillary thyroid carcinoma (PTC) detection. Design: The SELDI-TOF-MS protein profiles of patients with PTC, patients with benign nodular disease (BND), and healthy controls were analyzed to determine the sensitivity and specificity of SELDI-TOF-MS assay for PTC detection. Data analysis was performed to process the spectral data and classify the disease status of the patients. Setting: Academic tertiary care hospital. Patients: Serum samples were collected prospectively from 7 patients with PTC, 8 patients with BND, and 7 healthy control volunteers. Intervention: All patients diagnosed as having PTC or BND underwent thyroidectomy from October 21, 2004, to January 31, 2006. Main Outcome Measures: Twenty-two serum samples were analyzed. Results: Most protein peaks resolved by the SELDI-TOF-MS assay were in the range of 1 to 20 kDa. Classification tree analysis based on peak expression distinguished patients with PTC from those with BND with 85.7% sensitivity and 100% specificity. Serum samples from patients with PTC differed most significantly from those of patients with BND by the underexpression of a protein peak at 11 101 Da. Conclusions: This pilot study demonstrates that proteomic analysis of serum protein profiles distinguishes patients with PTC from patients with BND with a high degree of sensitivity and specificity. Further investigation into the clinical utility of this technology in PTC biomarker detection and surveillance is warranted.

Original languageEnglish (US)
Pages (from-to)198-202
Number of pages5
JournalArchives of Otolaryngology--Head and Neck Surgery
Volume134
Issue number2
DOIs
StatePublished - Feb 2008
Externally publishedYes

Fingerprint

Blood Proteins
Mass Spectrometry
Lasers
Sensitivity and Specificity
Papillary Thyroid cancer
Serum
Proteins
Thyroidectomy
Tertiary Healthcare
Tertiary Care Centers
Proteomics
Healthy Volunteers
Biomarkers
Outcome Assessment (Health Care)
Technology

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

Detection of papillary thyroid carcinoma with serum protein profile analysis. / Moretz, William H.; Gourin, Christine; Terris, David J.; Xia, Zhong Sheng; Liu, Zhongmin; Weinberger, Paul M.; Chin, Edward; Adam, Bao Ling.

In: Archives of Otolaryngology--Head and Neck Surgery, Vol. 134, No. 2, 02.2008, p. 198-202.

Research output: Contribution to journalArticle

Moretz, WH, Gourin, C, Terris, DJ, Xia, ZS, Liu, Z, Weinberger, PM, Chin, E & Adam, BL 2008, 'Detection of papillary thyroid carcinoma with serum protein profile analysis', Archives of Otolaryngology--Head and Neck Surgery, vol. 134, no. 2, pp. 198-202. https://doi.org/10.1001/archoto.2007.34
Moretz, William H. ; Gourin, Christine ; Terris, David J. ; Xia, Zhong Sheng ; Liu, Zhongmin ; Weinberger, Paul M. ; Chin, Edward ; Adam, Bao Ling. / Detection of papillary thyroid carcinoma with serum protein profile analysis. In: Archives of Otolaryngology--Head and Neck Surgery. 2008 ; Vol. 134, No. 2. pp. 198-202.
@article{f254532711ae4c61b9d65d81fe682546,
title = "Detection of papillary thyroid carcinoma with serum protein profile analysis",
abstract = "Objective: To determine the sensitivity and specificity of surface-enhanced laser desorption/ionization time-offlight mass spectrometry (SELDI-TOF-MS) for papillary thyroid carcinoma (PTC) detection. Design: The SELDI-TOF-MS protein profiles of patients with PTC, patients with benign nodular disease (BND), and healthy controls were analyzed to determine the sensitivity and specificity of SELDI-TOF-MS assay for PTC detection. Data analysis was performed to process the spectral data and classify the disease status of the patients. Setting: Academic tertiary care hospital. Patients: Serum samples were collected prospectively from 7 patients with PTC, 8 patients with BND, and 7 healthy control volunteers. Intervention: All patients diagnosed as having PTC or BND underwent thyroidectomy from October 21, 2004, to January 31, 2006. Main Outcome Measures: Twenty-two serum samples were analyzed. Results: Most protein peaks resolved by the SELDI-TOF-MS assay were in the range of 1 to 20 kDa. Classification tree analysis based on peak expression distinguished patients with PTC from those with BND with 85.7{\%} sensitivity and 100{\%} specificity. Serum samples from patients with PTC differed most significantly from those of patients with BND by the underexpression of a protein peak at 11 101 Da. Conclusions: This pilot study demonstrates that proteomic analysis of serum protein profiles distinguishes patients with PTC from patients with BND with a high degree of sensitivity and specificity. Further investigation into the clinical utility of this technology in PTC biomarker detection and surveillance is warranted.",
author = "Moretz, {William H.} and Christine Gourin and Terris, {David J.} and Xia, {Zhong Sheng} and Zhongmin Liu and Weinberger, {Paul M.} and Edward Chin and Adam, {Bao Ling}",
year = "2008",
month = "2",
doi = "10.1001/archoto.2007.34",
language = "English (US)",
volume = "134",
pages = "198--202",
journal = "Archives of Otolaryngology",
issn = "2168-6181",
publisher = "American Medical Association",
number = "2",

}

TY - JOUR

T1 - Detection of papillary thyroid carcinoma with serum protein profile analysis

AU - Moretz, William H.

AU - Gourin, Christine

AU - Terris, David J.

AU - Xia, Zhong Sheng

AU - Liu, Zhongmin

AU - Weinberger, Paul M.

AU - Chin, Edward

AU - Adam, Bao Ling

PY - 2008/2

Y1 - 2008/2

N2 - Objective: To determine the sensitivity and specificity of surface-enhanced laser desorption/ionization time-offlight mass spectrometry (SELDI-TOF-MS) for papillary thyroid carcinoma (PTC) detection. Design: The SELDI-TOF-MS protein profiles of patients with PTC, patients with benign nodular disease (BND), and healthy controls were analyzed to determine the sensitivity and specificity of SELDI-TOF-MS assay for PTC detection. Data analysis was performed to process the spectral data and classify the disease status of the patients. Setting: Academic tertiary care hospital. Patients: Serum samples were collected prospectively from 7 patients with PTC, 8 patients with BND, and 7 healthy control volunteers. Intervention: All patients diagnosed as having PTC or BND underwent thyroidectomy from October 21, 2004, to January 31, 2006. Main Outcome Measures: Twenty-two serum samples were analyzed. Results: Most protein peaks resolved by the SELDI-TOF-MS assay were in the range of 1 to 20 kDa. Classification tree analysis based on peak expression distinguished patients with PTC from those with BND with 85.7% sensitivity and 100% specificity. Serum samples from patients with PTC differed most significantly from those of patients with BND by the underexpression of a protein peak at 11 101 Da. Conclusions: This pilot study demonstrates that proteomic analysis of serum protein profiles distinguishes patients with PTC from patients with BND with a high degree of sensitivity and specificity. Further investigation into the clinical utility of this technology in PTC biomarker detection and surveillance is warranted.

AB - Objective: To determine the sensitivity and specificity of surface-enhanced laser desorption/ionization time-offlight mass spectrometry (SELDI-TOF-MS) for papillary thyroid carcinoma (PTC) detection. Design: The SELDI-TOF-MS protein profiles of patients with PTC, patients with benign nodular disease (BND), and healthy controls were analyzed to determine the sensitivity and specificity of SELDI-TOF-MS assay for PTC detection. Data analysis was performed to process the spectral data and classify the disease status of the patients. Setting: Academic tertiary care hospital. Patients: Serum samples were collected prospectively from 7 patients with PTC, 8 patients with BND, and 7 healthy control volunteers. Intervention: All patients diagnosed as having PTC or BND underwent thyroidectomy from October 21, 2004, to January 31, 2006. Main Outcome Measures: Twenty-two serum samples were analyzed. Results: Most protein peaks resolved by the SELDI-TOF-MS assay were in the range of 1 to 20 kDa. Classification tree analysis based on peak expression distinguished patients with PTC from those with BND with 85.7% sensitivity and 100% specificity. Serum samples from patients with PTC differed most significantly from those of patients with BND by the underexpression of a protein peak at 11 101 Da. Conclusions: This pilot study demonstrates that proteomic analysis of serum protein profiles distinguishes patients with PTC from patients with BND with a high degree of sensitivity and specificity. Further investigation into the clinical utility of this technology in PTC biomarker detection and surveillance is warranted.

UR - http://www.scopus.com/inward/record.url?scp=39649107938&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=39649107938&partnerID=8YFLogxK

U2 - 10.1001/archoto.2007.34

DO - 10.1001/archoto.2007.34

M3 - Article

C2 - 18283164

AN - SCOPUS:39649107938

VL - 134

SP - 198

EP - 202

JO - Archives of Otolaryngology

JF - Archives of Otolaryngology

SN - 2168-6181

IS - 2

ER -